Pharma
Expiring Pfizer Covid drug doses set to cost Europe $2.2bn
Soaring death counts spurred governments to invest heavily in Covid drug Paxlovid - but high vaccine uptake has curtailed the use of the drug
Stockpiles of Pfizer Paxlovid worth $2.2 billion (€2.36 billion) are set to expire by the end of next month in Europe and the UK as demand for the Covid-19 treatment plummets.
The outdated supply includes $1.1 billion worth of doses that had already expired as of November, according to the London-based analytics firm Airfinity. The UK has seen the biggest chunk go to waste with an estimated 1 million past-date courses at a cost of ...